Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-20-037827
Filing Date
2020-08-06
Accepted
2020-08-06 16:41:12
Documents
4
Effectiveness Date
2020-08-06

Document Format Files

Seq Description Document Type Size
1 S-8 dvax-s8.htm S-8 132918
2 EX-5.1 dvax-ex51_14.htm EX-5.1 9687
3 EX-23.1 dvax-ex231_53.htm EX-23.1 3535
4 GRAPHIC gemgimnnmdwb000001.jpg GRAPHIC 2794
  Complete submission text file 0001564590-20-037827.txt   151159
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-241674 | Film No.: 201082343
SIC: 2834 Pharmaceutical Preparations